Recent studies in Iran have investigated the role of air pollution as a significant factor in the occurrence of autoimmune diseases, including MS (
7,
25,
26). A study conducted between 2008 and 2016 in Isfahan found that the level of the Air Quality Index (AQI) was associated with the EDSS of MS patients, suggesting that air pollution may play a role in both the severity of MS (
27).
Outside of Iran, Jeanjean et al. (
28), in Strasbourg, France, conducted a study between 2000 and 2009 based on meteorological parameters, school holidays, and public holidays. They reported that the impact of PM
10 on the onset and recurrence of MS was more significant in the winter season than in the summer season, which is consistent with our study's findings that an increase in the number of dusty days is associated with an increase in the prevalence of MS in Khuzestan province. Similar positive associations between particulate matter air pollution and MS have been reported in other studies conducted in Iran, Italy, and Finland (
12,
13,
29).
In a cross-sectional study by Tateo et al. in Padua, Italy, the results indicated a strong association between the prevalence of MS and annual PM
2.5 concentration levels (r = 0.81, P < 0.001). Regression analysis further confirmed this relationship, revealing that MS cases were significantly associated with average PM
2.5 levels (β = 0.11, P < 0.001) (
30). In the United States, a case-control study by Lavery et al. showed that particulate matter (PM
2.5) (OR = 3.96, 95% CI: 1.42 - 11.1, P < 0.01), along with three other criteria pollutants (SO₂, CO, and lead), was significantly associated with an increased likelihood of pediatric MS (
31).
A case-crossover study by Jeanjean et al. in Paris, France, indicated that elevated NO
2 and PM
10 exposure were linked to an increased risk of MS relapse during the cold season (OR = 1.08, 95% CI: 1.03 - 1.14; OR = 1.06, 95% CI: 1.01 - 1.11, respectively). Moreover, a significant association was found between ozone (O
3) exposure and MS relapse risk during the hot season (OR = 1.16, 95% CI: 1.07 - 1.25) (
28). Similarly, a cross-sectional study by Ashtari et al. in Isfahan, Iran, revealed that the AQI level correlated with the degree of complete remission following the first attack of MS, with an odds ratio of 1.005 (95% CI: 1.004 - 1.006) (
27). In an ecological study by Heydarpour et al. conducted from 2003 to 2013 in Tehran, Iran, the findings indicated that MS cases exhibited a clustered distribution throughout the city. Additionally, a significant difference in exposure to pollutants such as PM
10, SO
2, NO
2, and NO
x (P < 0.001) was found when comparing MS cases to control subjects (
12).
Collectively, these studies underscore the significant association between particulate matter and MS, suggesting that exposure to air pollution, particularly particulate matter, may contribute to the prevalence and severity of this neurological disease.
Among the environmental factors considered, some studies have focused on the role of temperature, sunlight, and other meteorological parameters. In this regard, Vojinovic et al., in the city of Nis, Serbia, conducted a 5-year study and reported a significant positive correlation between total cloudiness and daily cloudiness with the number of MS relapses, although no relationship was found between disease activity and direct sunlight exposure in terms of hours, days, or sunny months (
32). In another study, Tremlett in southern Tasmania, Australia, observed a lower frequency of MS relapses in summer compared to winter, based on data collected from January 2002 to April 2005 (
33). Similarly, Ma and Zhang in China, from January 2002 to December 2012, associated MS onset/relapse with geographical latitude, temperature, and sunlight intensity. They observed the highest onset/relapse of MS in winter (134 cases) and the lowest in summer (97 cases). According to them, environmental factors, especially sun exposure, had the most significant impact on disease onset and relapse, while gender, age of onset, and disease duration were not significant (
34). On the other hand, in a study by Abella-Corral et al. conducted from 1997 to 2002, a significant difference in the prevalence of MS was reported between summer (high prevalence, peaking in June) and winter (low prevalence, lowest in December) (
35).
Some studies have examined the seasonal and monthly correlation between meteorological parameters and the prevalence and relapse of MS. For instance, Fundora-Hernandez et al. in Cuba, between April 2004 and November 2007, reported the highest frequency of MS prevalence in the second quarter of the year, from April to June, attributing it to the transition from winter to summer and the variable thermal oscillation during that period (
36). Additionally, Ogawa et al. in Japan, in 2004, investigated the correlation between temperature and MS exacerbation. They divided the 12 months of the year into 6 groups based on the monthly average temperature and found that the total number of disease attacks was higher in the warmest months (July and August) and the coldest months (January and February) compared to other months (
37).
Recently, in a population-based study involving three countries with high MS prevalence (Canada, Italy, and Norway), behavior and lifestyle related to sunlight exposure in summer and winter were examined. The results indicated that the risk of MS was higher among individuals who spent more time indoors during their childhood and protected themselves from the sun during the limited periods they spent outdoors. However, this protection did not affect the risk of MS among individuals who spent a considerable amount of time outdoors in the summer and a moderate amount of time outdoors in the winter (
38). These findings contrast with the results of our study regarding the role of temperature in the prevalence of MS. Our study did not observe a significant statistical correlation between average temperature and MS prevalence. Comparing our findings with those of the aforementioned studies is somewhat challenging, as they used different meteorological criteria related to the prevalence or exacerbation of MS, likely due to the substantial differences in climate between Khuzestan province and the other regions studied.
A significant limitation of this study is its reliance on aggregated data, which restricts the applicability of the findings to individual cases. Additionally, the exposure levels captured by air pollution and meteorological stations may not accurately reflect personal exposure. Since the study was ecological and population-based, it was not possible to account for individual confounders such as smoking, education, and other relevant variables. One of the strengths of this study is that, at the time it was conducted, no prior research had explored the connection between exposure to dusty days, temperature, wind speed, and the prevalence of MS in Khuzestan province, Iran.
Our study results showed that an increase in dusty days is associated with a higher prevalence of MS, highlighting the need for further investigation into the environmental factors affecting MS. These findings also suggest that public health interventions in Khuzestan province should prioritize monitoring and managing environmental factors, particularly during dusty seasons. Finally, future research should explore the mechanisms by which environmental factors, especially particulate matter, influence MS risk and consider longitudinal studies to assess changes over time.